In athymic nude mice, knockdown of TM9SF4 completely abolished the ovarian cancer growth and metastasis, highlighting TM9SF4 as an attractive molecular target for ovarian cancer therapy. The gene discussed is TM9SF4; the disease is ovarian carcinoma.